6,166
Views
2,537
CrossRef citations to date
0
Altmetric
Review

Drug delivery and nanoparticles: Applications and hazards

&
Pages 133-149 | Published online: 06 Jun 2008

References

  • AlbrechtCKnaapenAMBeckerThe crucial role of particle surface reactivity in respirable quartz induced reactive oxygen/nitrogen species formation and APE/Ref-1 induction in rat lungRespir Res2005612916266428
  • ÅkermanMEChanWCWLaakkonenPNonocrystal targeting in vivoPNAS200299126172112235356
  • AlyautdinRNPetrovVELangerKDelivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticlesJ Pharm Res1997143258
  • BallouBLagerholmBCErnstLANon-invasive imaging of quantum dots in miceBioconjug Chem200415798614733586
  • BaranETÖzerNHasirciVIn vivo half life of nanoencapsulated L-asparaginaseJ Mat Sc: Mat in Med200213111321
  • BazileDPrud’HommeCBassoulletM-TStealth PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes systemJ Pharm Sci19958449387629743
  • BenardiRJLoweryARThompsonPAImmunoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell linesJ Neurooncol200796 Epub ahead of print
  • BormPJParticle toxicology: from coal mining to nanotechnologyInhal Toxicol2002143112412028820
  • BormPJKreylingWToxicological hazards of inhaled nanoparticles – potential implications for drug deliveryJ Nanosc Nanotechnol2004452131
  • BormPJMuller-SchulteDNanoparticles in drug delivery and environmental exposure: same size, same risks?Nanomedicine200612354917716113
  • BormPJARobbinsDHauboldSThe potential risks of nanomaterials: a review carried out for ECETOCPart Fiber Toxicol2006311
  • BourgesJLGautierSEDelieFOcular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticlesInvest Ophthalmol Vis Sci2003443562912882808
  • BrookRDFranklinBCascioWAir pollution and vascular disease. A statement for healthcare professionals from the expert panel on population and prevention science of the American Heart AssociationCirculation200410926557115173049
  • BuxtonDBLeeSCWicklineSARecommendations of the National Heart, Lung, and Blood Institute Nanotechnology Working GroupCirculation200310827374214656908
  • Calderon-GarciduenasLReedWMaronpotRRBrain inflammation and Alzheimer’s-like pathology in individuals exposed to severe air pollutionToxicol Pathol200432650815513908
  • CampbellAOldhamMBecariaAParticulate matter in polluted air may increase biomarkers of inflammation in mouse brainNeurotoxicology2005261334015527881
  • CampenMJMcDonaldJDGigliottiAPCardiovascular effects of inhaled diesel exhaust in spontaneously hypertensive ratsCardiovasc Toxicol200333536114734832
  • CartyCLGehringUCyrysJSeasonal variability of endotoxin in ambient fine particulate matterJ Environm Monit200359538
  • CasconeMGLazzeriLCarmignaniCGelatin nanoparticles produced by a simple W/O emulsion as delivery system for methotrexateJ Mat Sc: Mat in Med2002135236
  • ChangJSChangKLBHwangDFIn vitro cytotoxicity of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell lineEnviron Sci Technol2007412064817410806
  • ChenLCNadziejkoCEffects of subchronic exposures to concentrated ambient particles (CAPs) in mice V CAPs exacerbate aortic plaque development in hyperlipidemic miceInhal Toxicol2005172172415804939
  • ChoSJMaysingerDJainMLong term exposure to CdTe quantum dots causes functional impairment in living cellsLangmuir20072319748017279683
  • ChoiAOChoSJDesbaratsJQuantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cellsJ Nanobiotechnology200712117295922
  • ConnorEEMwamukaJGoleAGold nanoparticles are taken up by human cells but do not cause acute cytotoxicitySmall20051325717193451
  • CostiganSThe toxicology of nanoparticles used in health care products2006 Available at the website of the Medicines and Healthcare products Regulatory Agency, Department of Health, UK. Accessed 20 November 2006 URL: http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&nodeId=996
  • CrommelinDJStormGLiposomes: from the bench to the bedJ Liposome Res20031333612725726
  • DamascelliBPatelliGLLanocitaRA novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findingsAm J Roentgenol200318125360312818869
  • De JongWHGeertsmaRERoszekBNanotechnology in medical applicationsPossible risks for human health. Report 265001002/20052005Bilthoven, The NethrlandsNational Institute for Public Health and the Environment (RIVM)
  • DemoyMGibaudSAndreuxJPSplenic trapping of nanoparticles: complementary approaches for in situ studiesPharm Res19971446389144732
  • DerfusAMChanWCWBhatiaSNProbing the cytotoxicity of semiconductor quantum dotsNano Letters200441118
  • DockeryDWPopeCAXuXAn association between air pollution and mortality in six U.S. citiesN Engl J Med1993329175398179653
  • DonaldsonKAitkenRTranLCarbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safetyToxicol Sci20069252216484287
  • DonaldsonKBrownDClouterAThe pulmonary toxicology of ultrafine particlesJ Aerosol Med2002152132012184871
  • DonaldsonKStoneVCurrent hypotheses on the mechanism of toxicity of ultrafine particlesAnn Ist Super Sanità20033940510
  • DonaldsonKStoneVClouterAUltrafine particlesOccup Environ Med2001582111611171936
  • DonaldsonKStoneVTranCLNanotoxicologyOccup Environ Med2004617272815317911
  • DonaldsonKTranLJimenezLACombustion-derived nanoparticles: a review of their toxicology following inhalation exposurePart Fibre Toxicol200521016242040
  • DreherKLToxicological highlight. Health and environmental impact of nanotechnology: Toxicological assessment of manufactured nanoparticlesToxicol Sc2004773514756123
  • DuncanRThe dawning era of polymer therapeuticsNat Rev Drug Disc2003234760
  • DuncanRIzzoLDendrimer biocompatibility and toxicityAdv Drug Deliv Rev20055722153716297497
  • DyerMHinchcliffeMWattsPNasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticlesPharm Res200219998100812180553
  • EdetsbergerMGaubitzerEValicEDetection of nanometer-sized particles in living cells using modern fluorescence fluctuation methodsBiochem Biophys Res Commun20053321091615896306
  • ElderAGeleinRSilvaVTranslocation of inhaled ultrafine manganese oxide particles to the central nervous systemEnviron Health Perspect20061141172816882521
  • European Technology Platform on Nanomedicine. 2005. Vision paper and basis for a strategic research agenda for nanomedicine. European Commission Luxembourg, Office for Official Publications of the European Commission, ISBN 92-894-9599-5
  • European Science Foundation. 2005. Policy Briefing (ESF), ESF Scientific Forward Look on Nanomedicine IREG Strasbourg, France, ISBN 2-912049-520, 2005.
  • FangCShiBPeiYYIn vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: Effect of MePEG molecular weight and particle sizeEur J Pharm Sci200627273616150582
  • FattalEVauthierCAynieIBiodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotidesJ Control Release199853137439741921
  • Fernández-UrrusunoRFattalEPorquetDEvaluation of liver toxicological effects induced by polyalkylcyanoacrylate nanoparticlesToxicol Appl Pharmacol199513027297871540
  • Fernández-UrrusunoRFattalEFégerJEvaluation of hepatic antioxidant systems after intravenous administration of polymeric nanoparticlesBiomaterials199718511179111956
  • FerrariMCancer nanotechnology: opportunities and challengesNat Rev Cancer200551617115738981
  • FishbeinIChornyMBanaiSFormulation and delivery mode affect disposition and activity of tyrphostin-loaded nanoparticles in the rat carotid modelArterioscler Thromb Vasc Biol2001211434911557668
  • GaoXTaoWLuWLectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administrationBiomaterials20062734829016510178
  • GibaudSDemoyMAndreuxJPCells involved in the capture of nanoparticles in hematopoietic organsJ Pharm Sci199685944508877884
  • GirardinFMembrane transporter proteins: a challenge for CNS drug developmentDialogues Cliin Neurosci2006831121
  • GomesAJLunardiLOMarchettiJMIndocyanine green nanoparticles useful for photomedicinePhotomed Laser Surg2006245142116942434
  • GranumBLovikMThe effect of particles on allergic immune responsesToxicol Sci20026571711752680
  • GuptaAKCurtisASGSurface modified supermagnetic nanoparticles for drug delivery: interaction studies with human firbroblasts in cultureJ Mater Sci: Mat in Med2004154936
  • GuptaMGuptaAKIn vitro cytotoxicity studies of hydrogel pullulan nanoparticles prepared by AOT/N-hexane micellar systemJ Pharm Pharmaceut Sci200473846
  • GuptaAKGuptaMSynthesis and surface engineering of iron oxide nanoparticles for biomedical applicationsBiomaterials2005263995402115626447
  • HainfeldJFSlatkinDNSmilowitzHMThe use of gold nanoparticles to enhance radiotherapy in micePhys Med Biol20044930915
  • HardmanRA toxicological review of quantum dots: toxicity depends on physicochemical and environmental factorsEnviron Health Perspect20061141657216451849
  • Health Council of the NetherlandsHealth significance of nanotechnologies2006The HagueHealth Council of the Netherlands publication no 2006 /06E http://www.healthcouncil.nl
  • HettANanotechnology. Small matter, many unknowns. Risk perception2004Swiss Re, Zurich, Switzerland
  • HirschLRStaffordRJBanksonJANanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidanceProc Natl Acad Sci USA2003100135495414597719
  • HoshinoAFujiokaKOkuTPhysicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modificationNano Lett2004421639
  • HoshinoAManabeNFujiokaKUse of fluorescent quantum dot bioconjugates for cellular imaging of immune cells, cell organelle labeling, and nanomedicine: surface modification regulates biological function, including cytotoxicityJ Artif Organs2007101495717846713
  • HuangMKhorELimL-YUptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylationPharm Res2004213445315032318
  • JECFA (Joint FAO/WHO Expert Committee on Food additives) Summary of Evaluations Performed by the Joint FAO/WHO Expert Committee on Food AdditivesINS 1752001 http://jecfa.ilsi.org/evaluation.cfm?chemical=GOLD%20(METALLIC)&keyword=GOLD
  • JinYKannaSWuMToxicity of luminescent silica nanoparticles to living cellsChem Res Toxicol20072011263317630705
  • KawanoTYamagataMTakahishiHStabilizing of plasmid DNA in vivo by PEG-modified cationic gold nanoparticles and the gene expression assisted with electrical pulsesJ Control Release2006111382916487614
  • KhandogaAStampflATakenakaSUltrafine particles exert prothrombotic but not inflammatory effects on the hepatic microcirculation in healthy mice in vivoCirculation20041091320515007013
  • KimSYLeeYMBaikDJToxic characteristics of methoxy poly(ethylene glycol)/poly(ε-caprolactone) nanospheres; in vitro and in vivo studies in the normal miceBiomaterials200324556312417178
  • KippJEThe role of solid nanoparticle technonogy in the parental delivery of poorly water-soluble drugsInt J Pharm20042841092215454302
  • KirchnerCLiedlTKuderaSCytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticlesNano Letters20055331815794621
  • KonanYNChevallierJGurnyREncapsulation of p-THPP into nanoparticles: cellular uptake, subcellular localization and effect of serum on photodynamic activityPhotochem Photobiol2003776384412870850
  • KoziaraJMLockmanPRAllenDDPaclitaxel nanoparticles for the potential treatment of brain tumorsJ Control Release2004992596915380635
  • KoziaraJMLockmanPRAllenDDThe blood brain barrier and brain drug deliveryJ Nanosci Nanotechnol2006627123517048477
  • KreuterJNanoparticulate systems for brain delivery of drugsAdv Drug Deliv Rev200147658111251246
  • KreuterJInfluence of the surface properties on nanoparticle-mediated transport of drugs to the brianJ Nanosci Nanotechnol20044484815503433
  • KreuterJRamgePPetrovVDirect evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs of the CNS via specific mechanisms requiring prior binding of drug to the nanoparticlesPharm Res2003204091612669961
  • KreylingWGSemmlerMMöllerWDosimetry and toxicology of ultrafine particlesJ Aerosol Med2004171405215294064
  • KreylingWGSemmlerMErbeFTranslocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very lowJ Toxicol Environ Health Part A20026515133012396866
  • LaiM-KChangC-YLienY-WApplication of gold nanoparticles to microencapsulation of thioridazineJ Control Release20061113526116478639
  • LamC-WJamesJTMcCluskeyRPulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillationTox Sc20047712634
  • LaVanDAMcGuireTLangerRSmall scale systems for in vivo drug deliveryNat Biotechnol20032111849114520404
  • LenaertsVNagelkerkeJFVan BerkelTJIn vivo uptake of polyisobutyl cyanoacrylate nanoparticles by rat liver Kupffer, endothelial, and parenchymal cellsJ Pharm Sci19847398026470966
  • LinWHuangYWZhouXDIn vitro toxicity of silica nanoparticles in human lung cancer cellsToxicol Appl Pharmacol2006217252917112558
  • LockmanPRKoziaraJMMumperRJNanoparticle surface charges alter blood-brain barrier integrity and permeabilityJ Drug Target2004126354115621689
  • LockmanPRKoziaraJMRoderKEIn vivo and in vitro assessment of baseline blood-brain-barrier parameters in the presence of novel nanoparticlesPharm Res2003207051312751624
  • LooCLinAHirschLNanoshell-enabled photonics-based imaging and therapy of cancerTechnol Cancer Res Treat20043334014750891
  • LovernSBKlaperRDaphnia magna mortality when exposed to titanium dioxide and fullerene (C60) nanoparticlesEnviron Toxicol Chem2006251132716629153
  • LovricJBazziHSCuieYDifferences in subcellular distribution and toxicity of green and red emitting CdTe quantum dotsJ Mol Med2005833778515688234
  • LovricJChoSJWinnikFMUnmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell deathChem Biol20051211596116298294
  • LoweryARGobinAMDayEsImmunonanoshells for targeted photothermal ablation of tumor cellsInt J Nanomedicine200611495417722530
  • MetselaarJMStormGLiposomes in the treatment of inflammatory disordersExpert Opin Drug Deliv200524657616296768
  • MichaelisKHoffmannMMDreisSCovalent linkage of apolipoprotein E to albumin naniparticles strongly enhances drug transport into the brainJ Pharmacol Exp Ther200631712465316554356
  • MinkoTPakunluRIWangYNew generation of liposomal drugs for cancerAnticancer Agents Med Chem200665375217100558
  • MillsNLTornqvistHRobinsonSDDiesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysisCirculation200511239303616365212
  • MoghimiSMHunterACMurrayJCLong-circulating and target specific nanoparticles: theory and practicePharmacol Rev20015328331811356986
  • Monteiro-RiviereNANemanichRJInmanAOMulti-walled carbon nanotube interactions with human epidermal keratinocytesToxicol Lett20051553778415649621
  • MullerJHuauxFMoreauNRespiratory toxicity of multi-wall carbon nanotubesToxicol Appl Pharmacol20052072213116129115
  • MullerRHMaderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm2000501617710840199
  • NaKLeeKHLeeDHBiodegradable thermo-sensitive nanoparticles from poly(L-lactic acid)/poly(ethylene glycol) alternating multiblock copolymer for potential anti-cancer drug carrierEur J Pharm Sci2006271152216253487
  • NelAXiaTMadlerLToxic potential of materials at the nanolevelScience2006311622716456071
  • NemmarAHoetPHVanquickenborneBPassage of inhaled particles into the blood circulation in humansCirculation20021054111411815420
  • NemmarAHoylaertsMFHoetPHSize effect of intraytracheally instilled particles on pulmonary inflammation and vascular thrombosisToxicol Appl Pharmacol2003186384512583991
  • NiidomeTYamagataMOkamotoYPEG-modified gold nanorods with a stealth character for in vivo applicationsJ Control Release2006114343716876898
  • NobsLBucheggerFGurnyRPoly(lactic acid) nanoparticles labeled with biologically active Neutravidin™ for active targetingEur J Pharm Biopharm2004584839015451522
  • OberdörsterEManufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bassEnviron Health Perspect200411210586215238277
  • OberdörsterGSignificance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particlesInhal Toxicol19968Suppl738911542496
  • OberdörsterGMaynardADonaldsonKPrinciples for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategyPart Fibre Toxicol20052816209704
  • OberdörsterGOberdörsterEOberdörsterJNanotoxicology: An emerging discipline evolving from studies of ultrafine particlesEnviron Health Perspect20051138233916002369
  • OberdörsterGSharpZAtudoreiVTranslocation of inhaled ultrafine particles to the brainInhalation Toxicol20041643745
  • OlivierJCFenartLChauvetRIndirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicityPharm Res19991618364210644071
  • O’NealDPHirschLRHalasNJPhoto-thermal tumor ablation in mice using near infrared-absorbing nanoparticlesCancer Lett2004209171615159019
  • PaciottiGFMeyerLWeinreichDColloidal gold: a novel nanoparticle vector for tumor directed drug deliveryDrug Deliv2004111698315204636
  • PanyamJZhouWZPrabhaSRapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene deliveryFASEB J20021612172612153989
  • PardridgeWMBlood-brain barrier deliveryDrug Discovery Today200712546117198973
  • PeracchiaMTFattalEDesmaeleDStealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targetingJ Control Release199960121810370176
  • PopeCABurnettRTThurstonGDCardiovascular mortality and long term exposure to particulate air pollution: epidemiological evidence of genearal pathophysiological pathways of diseaseCirculation200410971714676145
  • PrinzenLMiserusR-JJHMDirksenAOptical and magnetic resonance imaging of cell death and platelet activation using annexin A5-functionalized quantum dotsNano Lett200779310017212446
  • RadomskiAJuraszPAlonso-EscolanoDNanoparticle-induced platelet aggregation and vascular thrombosisBr J Pharmacol20051468829316158070
  • RadtBSmithTACarusoFOptically addressable nanostructured capsulesAdv Mater20041621849
  • Ravi KumarMNGametiMMohapatraSSCationic silica nanoparticles as gene carriers: synthesis, characterization and transfection efficiency in vitro and in vivoJ Nanosci Nanotechnol200448768115570975
  • RennORocoMCNanotechnology and the need for risk governanceJ Nanoparticle Research2006815391
  • Ricci-JuniorEMarchettiJMPreparation, characterization, photocytotoxicity assay of PLGA nanoparticles containing zinc(II) phthalocyanine for photodynamic therapy useJ Microencapsul2006235233816980274
  • SaezAGuzmanMMolpeceresJFreeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugsEur J Pharm Biopharm2000503798711072195
  • SayesCMGobinAMAusmanKDNano-C60 cytotoxicity is due to lipid peroxidationBiomaterials20052675879516005959
  • SayesCMLiangFHudsonJLFunctionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitroToxicol Lett20061611354216229976
  • [SCENIHR] EU Scientific Committee on Emerging and Newly Identified Health RisksModified Opinion (after public consultation) on the appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies2006 SCENIHR/002/05 Accessed 23 June 2006 URL: http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_003b.pdf
  • SchinsRPDuffinRHohrDSurface modification of quartz inhibits toxicity, particle uptake, and oxidative DNA damage in human lung epithelial cellsChem Res Toxicol20021511667312230410
  • SchinsRPFLightbodyJHBormPJAInflammatory effects of coarse and fine particulate matter in relation to chemical and biological constituentsToxicol Appl Pharmacol200419511114962500
  • SekiJSonokeSSahekiAA nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targetingInt J Pharm2004273758315010132
  • SeniorJCrawleyJCWFisherDInfluence of surface hydrophobicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesiclesBiochim Biophys Acta1985106277821998713
  • SeniorJGregoriadisGIs half-life of circulating small unilamellar liposomes determined by changes in their permeability?FEBS Lett1982145109146897042
  • ShenoyDFuWLiJSurface functionalization of gold nanoparticles using hetero-bifunctional poly(ethylene glycol) spacer for intracellular tracking and deliveryInt J Nanomedicine2006151716467923
  • ShimJSeok KangHParkWSTransdermal delivery of minoxidil with block copolymer nanoparticlesJ Control Release2004974778415212879
  • ShioharaAHoshinoAHanakiKOn the cytotoxicity of quantum dotsMicrobiol Immunol2004486697515383704
  • ShvedovaAACastranovaVKisinERExposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cellsJ Toxicol Environm Health Part A200366190926
  • SternJMStanfieldJLotanYEfficacy of laser-activated gold nanoshells in ablating prostate cancer cells in vitroJ Endourol2007219394317867958
  • SuC-HSheuH-SLinC-YNanoshell resonance imaging contrast agentsJ Am Chem Soc200612921394617263533
  • SuwaTHoggJCQuinlanKBParticulate air pollution induces progression of atherosclerosisAm Coll Cardiol2002399435
  • SvensonSTomaliaDADendrimers in biomedical applications – reflections on the fieldAdv Drug Del Rev200557210629
  • TakenakaSKargeEKreylingWGDistribution pattern of inhaled ultrafine gold nanoparticles in the rat lungInhalation Toxicol20061873340
  • The Royal Society and The Royal Academy of EngineeringNanoscience and nanotechnologies: opportunities and uncertainties2004London, UK
  • TiwariSBAmijiMMA review of nanocarrier-based CNS delivery systemsCurrent Drug Delivery200632193216611008
  • Tomazic-JezicVJMerrittKUmbreitTHSignificance of the type an dsize of biomaterial particles on phagocytosis and tissue distributionJ Biomed Mater Res200155523911288080
  • WarheitDBLaurenceBRReedKLComparative pulmonary toxicity assessment of single-wall carbon nanotubes in ratsToxicol Sci2004771172514514968
  • WeissenbockAWirthMGaborFWGA grafted PLGA-nanospheres: preparation and association with Caco-2 cellsJ Contr Release20049938392
  • WinKYFengSSIn vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulationBiomaterials20062722859116313953
  • WissingSAKayserOMüllerRHSolid lipid nanoparticles for parental drug deliveryAdv Drug Deliv Rev20045612577215109768
  • XiaTKovochichMBrantJComparison of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigmNano Lett20066179480716895376
  • YamakoshiYUmezawaNRyuAActive oxygen species generated from photo-excited fullerene (C-60) as potential medicines: O2− versus 1O2 J Am Chem Soc200312512803914558828
  • ZhangLHuYJiangXCamptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in miceJ Control Release2004961354815063036
  • ZhuSOberdörsterEHaaschMLToxicity of an engineered nanoparticle (fullerene, C60) in to aquatic species, Daphnia and flathead minnowMar Environ Res200662SupplS5916709433